Excess comorbidities associated with malignant hyperthermia diagnosis in pediatric hospital discharge records

Guohua Li1, Joanne E Brady, Henry Rosenberg

  • 1Department of Anesthesiology, Columbia University College of Physicians and Surgeons, 622 West 168th Street, New York, NY 10032, USA. GL2240@columbia.edu

Insights

Malignant hyperthermia (MH) in children is significantly linked to musculoskeletal and circulatory system diseases, and congenital anomalies. Muscular dystrophies show the strongest association, warranting further research into MH susceptibility.

Area of Science:

  • Pediatric Anesthesiology
  • Medical Genetics
  • Health Informatics

Background:

  • Malignant hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder of skeletal muscle.
  • Previous case reports suggest associations between MH and various genetic conditions.
  • Quantitative data on comorbidities in pediatric MH cases are limited.

Purpose of the Study:

  • To quantitatively assess the excess comorbidities associated with a diagnosis of malignant hyperthermia (MH) in pediatric hospital discharge records.
  • To identify specific disease groups and conditions that are disproportionately represented in children with MH.

Main Methods:

  • Utilized data from the Kids' Inpatient Database (KID) for 2000, 2003, and 2006, encompassing a large sample of US pediatric hospital discharges.
  • Calculated standardized morbidity ratios (SMRs) and 95% confidence intervals (CIs) comparing children with MH diagnosis to the general pediatric inpatient population.
  • Analyzed comorbidities across major disease groups and specific medical conditions.

Main Results:

  • Out of nearly 6 million pediatric discharges, 175 had an MH diagnosis.
  • Children with MH showed significantly higher rates of musculoskeletal/connective tissue diseases (SMR 5.7), circulatory system diseases (SMR 3.3), and congenital anomalies (SMR 3.2).
  • Muscular dystrophies were the most strongly associated specific diagnosis (SMR 31.3).

Conclusions:

  • Significant associations exist between malignant hyperthermia (MH) and diseases of the musculoskeletal system, connective tissue, and circulatory system in children.
  • Congenital anomalies are also more prevalent in pediatric MH cases.
  • Further investigation is needed to explore the clinical utility of these comorbidities in assessing MH susceptibility.
Abstract

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.
Homeostatic Imbalances in Body Temperature01:19

Homeostatic Imbalances in Body Temperature

Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...
Types of Fever01:25

Types of Fever

Fever can be triggered by several factors, including infections, nervous system disorders, certain cancers, blood diseases like leukemia, embolism, thrombosis, heatstroke, dehydration, surgical trauma, crushing injuries, and allergic reactions.
Here are the different types of fever:
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...